In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...
Charlottesville, Va, Jan. 21, 2026 (GLOBE NEWSWIRE) -- A scientific discovery aimed at stopping dangerous immune-system ...
Drawing from research on sepsis and complement biology, they developed the monoclonal antibody vilobelimab to block overactive inflammatory responses in patients with severe inflammatory diseases ...
(RTTNews) - InflaRx N.V. (IFRX), a biopharmaceutical company specializing in anti-inflammatory therapeutics, announced on Wednesday that the European Commission or EC has granted marketing ...
DUBLIN--(BUSINESS WIRE)--The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration, Treatment Mode, ...
ARDS is a life-threatening condition marked by severe pulmonary inflammation and fluid accumulation in the lungs. Even with aggressive medical management, 40% of ARDS patients do not survive, and ...
Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...
Waiting for Response on Pre-IND Submission for TSC in COVID-19 ARDS On April 27, 2020, Diffusion Pharmaceuticals, Inc. DFFN announced the company's Pre-IND submission to the U.S. FDA for the use of ...
Bringing the newborn home is such a special and emotional experience for parents, and yet with it come some unexpected challenges. One concern is Newborn Respiratory Distress Syndrome, wherein the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results